Cell and gene manufacturing: What does Australia really need?
Tracks
Track 3
| Friday, November 1, 2024 |
| 11:45 AM - 12:30 PM |
Details
Australia’s advanced manufacturing sector is expanding quickly and the question everyone asks is “How much is needed and where?” This session will call for national coordination and collaboration to maximise opportunities for the ecosystem. This will include asking how we can effectively work across state borders, leverage strengths and capabilities, and better understand workforce needs and job growth areas.
Speaker
A/Prof. Emily Blyth
Haematologist, Blood Transplant and Cell Therapies Program; Clinical Lead, Immune Effector Cell Service
Westmead Hospital; VP, ISCT ANZ
Panellist
Dr. Michael May
President & CEO
CCRM
Panellist
Dr Sharon Sagnella
Research & Development Manager
Royal Price Alfred Hospital
Panellist
Dominic Wall
Executive Director, Business Ventures, Peter MacCallum Cancer Centre; Chief Scientific Officer
Cell Therapies
Panellist
